miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma

Activation of mammalian target of rapamycin (mTOR) signaling pathway is associated with poor prognosis of epithelial ovarian cancer. The TSC1-TSC2 complex is a critical negative regulator of mTOR signaling. Here, we demonstrated that TSC1 was frequently downregulated in high-grade serous ovarian car...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Cell Death Differ
Główni autorzy: Wang, Yuqiong, Zhang, Xiyu, Tang, Wei, Lin, Zhenghong, Xu, Limei, Dong, Ruifen, Li, Yinuo, Li, Jieyin, Zhang, Zaixin, Li, Xiangzhi, Zhao, Ling, Wei, Jian-Jun, Shao, Changshun, Kong, Beihua, Liu, Zhaojian
Format: Artigo
Język:Inglês
Wydane: Nature Publishing Group 2017
Hasła przedmiotowe:
Original Paper
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5686346/
https://ncbi.nlm.nih.gov/pubmed/28800130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cdd.2017.129
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy